EP3713919 - Bibliographic data
FORMES CRISTALLINES DE N-(4-(4-(CYCLOPROPYLMÉTHYL) PIPÉRAZINE-1-CARBONYL)PHÉNYL)QUINOLÉINE-8-SULFONAMIDE
| Last update | 18/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Agios Pharmaceuticals, Inc. 88 Sidney Street
Cambridge, MA 02139
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Jacob SIZEMORE 8 Vista Drive
Shrewsbury
MA 01545
États-Unis d'Amérique
Liting GUO Qinshui Langting Blvd. 18
2 HongFan Road
Suzhou Industrial Park
Suzhou 215000
Chine
Mahmoud MIRMEHRABI 36 Roxbury Crescent
Halifax
Nova Scotia B3M 4T1
Canada
Yeqing SU 2225 Monastery Lane Apt 310
Halifax
Nova Scotia B3L 4R1
Canada
|
| (74) Agent |
Mail recipient Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
Royaume-Uni
|
| (21) Request number | EP18821779.8 |
|---|---|
| (22) Request date | 21/11/2018 |
| (11) Publication number | EP3713919 |
|---|---|
| Publication date | 02/08/2023 |
| (54) Title of the invention | FORMES CRISTALLINES DE N-(4-(4-(CYCLOPROPYLMÉTHYL) PIPÉRAZINE-1-CARBONYL)PHÉNYL)QUINOLÉINE-8-SULFONAMIDE |
|---|---|
| (51) International classification | C07D 215/36, A61P 7/06, A61K 31/4709 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201762589822 P |
|---|---|
| Initial application | None |
| Divisional application | EP23186155.0 /EP4285904 None |
| Expected annuity | Annuity: 8 - Amount: 160 € - Due date 01/12/2025 |
|---|---|
| Last annuity | Annuity: 7 - Payment date 05/11/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 02/08/2023 |